Radiopharmaceuticals for targeting the angiogenesis marker alpha(v)beta(3)
- PMID: 12897712
Radiopharmaceuticals for targeting the angiogenesis marker alpha(v)beta(3)
Abstract
A common feature of solid tumors is the formation of new blood vessels (angiogenesis) within the tumor. A receptor called alpha(v)beta(3) is found on endothelial cells lining newly growing blood vessels at a higher density than on mature blood vessels. This receptor may provide a target for radioligands to permit imaging of a wide variety of solid tumors. The radioligands may range from macromolecules such as native ligands or monoclonal antibodies, to small proteins to very small peptides. The differing characteristics of these bio-molecules have an affect on target delivery and clearance time.
Similar articles
-
Radiotracer-based strategies to image angiogenesis.Q J Nucl Med. 2003 Sep;47(3):189-99. Q J Nucl Med. 2003. PMID: 12897710 Review.
-
Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.Bioconjug Chem. 2004 Sep-Oct;15(5):988-96. doi: 10.1021/bc049961j. Bioconjug Chem. 2004. PMID: 15366951
-
[Angiogenesis in cancer and its detection with radiolabeled biomolecules].Hell J Nucl Med. 2005 Jan-Apr;8(1):5-11. Hell J Nucl Med. 2005. PMID: 15886745 Review. Greek, Modern.
-
Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients.J Nucl Med. 2005 Aug;46(8):1333-41. J Nucl Med. 2005. PMID: 16085591 Clinical Trial.
-
A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis.Nanomedicine. 2005 Jun;1(2):110-4. doi: 10.1016/j.nano.2005.03.008. Nanomedicine. 2005. PMID: 17292065 Review. No abstract available.
Cited by
-
Integrin alpha v beta 3-targeted imaging of lung cancer.Neoplasia. 2005 Mar;7(3):271-9. doi: 10.1593/neo.04538. Neoplasia. 2005. PMID: 15799827 Free PMC article.
-
In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model.Mol Imaging Biol. 2006 Nov-Dec;8(6):315-23. doi: 10.1007/s11307-006-0059-y. Mol Imaging Biol. 2006. PMID: 17053862
-
Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer.Bioconjug Chem. 2008 Jan;19(1):201-10. doi: 10.1021/bc7002988. Epub 2007 Dec 11. Bioconjug Chem. 2008. PMID: 18069778 Free PMC article.
-
The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.Perspect Medicin Chem. 2008 Apr 10;2:57-73. Perspect Medicin Chem. 2008. PMID: 19787098 Free PMC article.
-
A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for Maytansinoid.Theranostics. 2017 Jul 23;7(13):3306-3318. doi: 10.7150/thno.20242. eCollection 2017. Theranostics. 2017. PMID: 28900511 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources